Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Urinary Exosomes as a Risk Stratification Tool Among Men With Elevated PSAs and Negative Prostate MRIs

NCT06966089 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT06966089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06966089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Urinary Exosomes as a Risk Stratification Tool Among Men With Elevated PSAs and Negative Prostate MRIs
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
August 31, 2026
Enrollment
425 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer